LLY
Valuation Healthcare · Drug Manufacturers - General Data as of 2026-03-31P/E Ratio · Metrics
P/E Ratio
27.85
PEG Ratio
0.15
Dividend Yield
-
Gross Margin
81.93%
Net Margin
37.36%
Revenue CAGR 3Y
41.69%
ROE
94.83%
ROA
25.38%
Buyback Yield
0.23%
Current Ratio
1.50
Magic Earn Yield
4.11%
Altman Z-Score
6.75
Fair Value River
Score
Valuation 56
Profitability 89
Growth 100
Health 75
Yield 4